As of June 2024 Adicet Bio has a market cap of $0.11 Billion. This makes Adicet Bio the world's 7340th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.11 B | 46.05% |
2023 | $81.58 M | -78.7% |
2022 | $0.38 B | -44.04% |
2021 | $0.68 B | 147.63% |
2020 | $0.27 B |
On Jun 1st, 2024 the market cap of Adicet Bio was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Novartis NVS | $210.42 B | 176,504.85% | ๐จ๐ญ Switzerland |
Pfizer PFE | $162.40 B | 136,200.72% | ๐บ๐ธ USA |
Merck MRK | $317.96 B | 266,760.89% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $19.17 B | 15,993.45% | ๐ฎ๐ฑ Israel |
Hawkins HWKN | $1.82 B | 1,432.55% | ๐บ๐ธ USA |
Quaker Houghton KWR | $3.26 B | 2,638.08% | ๐บ๐ธ USA |